Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Edgewell Stock Plummets on Sun Care Weakness, But Long-Term Hopes Remain

Felix Baarz by Felix Baarz
August 30, 2025
in Analysis, Automotive & E-Mobility, Banking & Insurance, Consumer & Luxury, Dividends, Dow Jones, Earnings, Energy & Oil, Ethereum & Altcoins, Healthcare, Hydrogen, Stocks, Tech & Software, Turnaround
0
Edgewell Personal Care Stock
0
SHARES
232
VIEWS
Share on FacebookShare on Twitter

A disappointing summer for sun care sales has triggered a significant downturn for consumer goods conglomerate Edgewell Personal Care. The company, known for its Banana Boat and Wilkinson Sword brands, is facing investor skepticism after reporting dismal quarterly results that sent its shares tumbling. However, some strategic moves suggest potential recovery for patient investors.

Q3 Fiscal 2025 Results Spark Sell-Off

Edgewell’s third fiscal quarter proved challenging, with the company falling short of revenue expectations. It posted sales of $627.2 million, significantly below the anticipated $658.5 million and representing a 3.2% decrease year-over-year. The situation appeared more concerning when examining organic revenue, which declined by 4.2%.

The company’s adjusted earnings per share also disappointed, dropping to $0.92 from $1.22 in the comparable period. This fell well below the $1.01 per share that market analysts had projected. Management attributed the weak performance primarily to poor sun care product sales across North America and parts of Latin America due to unfavorable weather conditions. Consequently, net income plummeted 40.6% to $29.1 million.

Analyst Community Responds With Downgrades

Financial institutions quickly adjusted their outlooks for Edgewell following the earnings release:

  • UBS maintained its neutral rating but reduced its price target from $28 to $21
  • Barclays lowered its target price from $26 to $22
  • Morgan Stanley upgraded the stock to “Equal Weight” while simultaneously cutting its target from $26 to $23

A single positive note emerged from Canaccord Genuity, which maintained its buy recommendation despite trimming its price target from $35 to $32. The firm characterized the stock as oversold in the current market.

Should investors sell immediately? Or is it worth buying Edgewell Personal Care?

Institutional Investors Show Diverging Strategies

The reaction from major investment firms presented a mixed picture during the market turmoil. While retail investors engaged in widespread selling, several institutional players actually increased their holdings:

  • Charles Schwab Investment Management boosted its position by 7.8% to 881,101 shares
  • Public Sector Pension Investment Board expanded its stake by 40.5% to 170,649 shares
  • Nuveen LLC established a new position comprising 113,237 shares

This bullish sentiment wasn’t universal, however. Gabelli Funds reduced its exposure by 14.7%, highlighting the divided opinions on Edgewell’s recovery prospects.

Dividend Commitment Provides Stability

Despite the disappointing quarterly performance, Edgewell reaffirmed its commitment to shareholder returns. The company confirmed its quarterly dividend of $0.15 per share, payable in October. At the current share price, this distribution represents an attractive dividend yield of approximately 2.6%.

The coming quarters will determine whether the company’s sun care troubles were merely weather-related or indicative of deeper structural challenges. The consistent dividend policy may help maintain investor confidence as Edgewell navigates this difficult period.

Ad

Edgewell Personal Care Stock: Buy or Sell?! New Edgewell Personal Care Analysis from February 7 delivers the answer:

The latest Edgewell Personal Care figures speak for themselves: Urgent action needed for Edgewell Personal Care investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Edgewell Personal Care: Buy or sell? Read more here...

Tags: Edgewell Personal Care
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Next Post
Zedge Stock

Zedge Stock Plunge: Was This Decline Predictable?

Ormat Stock

Ormat Technologies Powers Ahead with Strategic Geothermal Expansion

Oric Pharmaceuticals Inc Stock

Oric Pharmaceuticals Positions for Critical Growth Phase with Robust Pipeline and Funding

Recommended

MDB stock news

Insider Trading Activity and Institutional Investment in MongoDB, Inc.: Key Developments to Monitor for Shareholders

3 years ago
Paramount Global Stock

Paramount Global Initiates Major Workforce Reduction Following Merger

3 months ago
Coinbase Stock

Coinbase Bets on Prediction Markets Amid Crypto Uncertainty

3 months ago
Nvidia Stock

Nvidia’s Strategic Gambits Fuel Market Speculation

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Trending

Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

by Jackson Burston
February 7, 2026
0

A strategic acquisition in Texas is proving to be a significant catalyst for Guaranty Bancshares. The bank's...

Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy
  • ServiceNow Shares Face Market Skepticism Despite Record Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com